[Catecholamine inhibition of cardiac Na+ channel via stimulation of beta-adrenoceptors].
I
I
Hisatome
J
J
Miyamoto
H
H
Kotake
T
T
Hata
M
M
Furuse
H
H
Mashiba
T
T
Kiyosue
S
S
Imanishi
M
M
Arita
D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002395:Catecholamines / Q000502:physiology*; D000242:Cyclic AMP / Q000378:metabolism; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects*; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism*; D011188:Potassium / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D012964:Sodium / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D007473:Ion Channels; D011943:Receptors, Adrenergic, beta; D012964:Sodium; D000242:Cyclic AMP; D007545:Isoproterenol; D011188:Potassium